1	Inactivation	inactivation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	tax	tax	_	_	_	_	_	_	_
7	protein	protein	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	T-cell	t-cell	_	_	_	_	_	_	_
11	leukemia	leukemia	_	_	_	_	_	_	_
12	virus	virus	_	_	_	_	_	_	_
13	type	type	_	_	_	_	_	_	_
14	1	1	_	_	_	_	_	_	_
15	:	:	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	potential	potential	_	_	_	_	_	_	_
18	mechanism	mechanism	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	constitutive	constitutive	_	_	_	_	_	_	_
21	induction	induction	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	resting	rest	_	_	_	_	_	_	_
3	T	t	_	_	_	_	_	_	_
4	lymphocytes	lymphocyte	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	transcription	transcription	_	_	_	_	_	_	_
8	factor	factor	_	_	_	_	_	_	_
9	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	sequestered	sequester	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	cytoplasm	cytoplasm	_	_	_	_	_	_	_
15	via	via	_	_	_	_	_	_	_
16	interactions	interaction	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	members	member	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	I	i	_	_	_	_	_	_	_
22	kappa	kappa	_	_	_	_	_	_	_
23	B	B	_	_	_	_	_	_	_
24	family	family	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	inhibitors	inhibitor	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	including	include	_	_	_	_	_	_	_
29	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	During	during	_	_	_	_	_	_	_
2	normal	normal	_	_	_	_	_	_	_
3	T-cell	t-cell	_	_	_	_	_	_	_
4	activation	activation	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	rapidly	rapidly	_	_	_	_	_	_	_
9	phosphorylated	phosphorylate	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	ubiquitinated	ubiquitinate	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	degraded	degrade	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	26S	26s	_	_	_	_	_	_	_
18	proteasome	proteasome	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	thus	thus	_	_	_	_	_	_	_
21	permitting	permit	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	release	release	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	functional	functional	_	_	_	_	_	_	_
26	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	its	its	_	_	_	_	_	_	_
5	transient	transient	_	_	_	_	_	_	_
6	pattern	pattern	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	induction	induction	_	_	_	_	_	_	_
10	during	during	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	immune	immune	_	_	_	_	_	_	_
13	response	response	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	constitutively	constitutively	_	_	_	_	_	_	_
18	activated	activate	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	expressing	express	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	Tax	tax	_	_	_	_	_	_	_
24	transforming	transforming	_	_	_	_	_	_	_
25	protein	protein	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	human	human	_	_	_	_	_	_	_
28	T-cell	t-cell	_	_	_	_	_	_	_
29	leukemia	leukemia	_	_	_	_	_	_	_
30	virus	virus	_	_	_	_	_	_	_
31	type	type	_	_	_	_	_	_	_
32	I	i	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	HTLV-1	HTLV-1	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Recent	recent	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	HTLV-1	HTLV-1	_	_	_	_	_	_	_
6	Tax	Tax	_	_	_	_	_	_	_
7	targets	target	_	_	_	_	_	_	_
8	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	ubiquitin-proteasome	ubiquitin-proteasome	_	_	_	_	_	_	_
12	pathway	pathway	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	it	it	_	_	_	_	_	_	_
4	remains	remain	_	_	_	_	_	_	_
5	unclear	unclear	_	_	_	_	_	_	_
6	how	how	_	_	_	_	_	_	_
7	this	this	_	_	_	_	_	_	_
8	viral	viral	_	_	_	_	_	_	_
9	protein	protein	_	_	_	_	_	_	_
10	induces	induce	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	persistent	persistent	_	_	_	_	_	_	_
13	rather	rather	_	_	_	_	_	_	_
14	than	than	_	_	_	_	_	_	_
15	transient	transient	_	_	_	_	_	_	_
16	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
17	response	response	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	report	report	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	provide	provide	_	_	_	_	_	_	_
7	evidence	evidence	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	addition	addition	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	acting	act	_	_	_	_	_	_	_
13	on	on	_	_	_	_	_	_	_
14	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	Tax	Tax	_	_	_	_	_	_	_
17	stimulates	stimulate	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	turnover	turnover	_	_	_	_	_	_	_
20	Of	of	_	_	_	_	_	_	_
21	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
22	via	via	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	related	related	_	_	_	_	_	_	_
25	targeting	targeting	_	_	_	_	_	_	_
26	mechanism	mechanism	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Like	like	_	_	_	_	_	_	_
2	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	Tax-mediated	tax-mediated	_	_	_	_	_	_	_
5	breakdown	breakdown	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	transfected	transfecte	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	lymphocytes	lymphocyte	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	blocked	block	_	_	_	_	_	_	_
14	either	either	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	cell-permeable	cell-permeable	_	_	_	_	_	_	_
17	proteasome	proteasome	_	_	_	_	_	_	_
18	inhibitors	inhibitor	_	_	_	_	_	_	_
19	or	or	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	mutation	mutation	_	_	_	_	_	_	_
22	Of	of	_	_	_	_	_	_	_
23	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
24	at	at	_	_	_	_	_	_	_
25	two	two	_	_	_	_	_	_	_
26	serine	serine	_	_	_	_	_	_	_
27	residues	residue	_	_	_	_	_	_	_
28	present	present	_	_	_	_	_	_	_
29	within	within	_	_	_	_	_	_	_
30	its	its	_	_	_	_	_	_	_
31	N-terminal	n-terminal	_	_	_	_	_	_	_
32	region	region	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Despite	despite	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	dual	dual	_	_	_	_	_	_	_
4	specificity	specificity	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	HTLV-1	HTLV-1	_	_	_	_	_	_	_
7	Tax	Tax	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
12	at	at	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	protein	protein	_	_	_	_	_	_	_
15	level	level	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	Tax	Tax	_	_	_	_	_	_	_
18	selectively	selectively	_	_	_	_	_	_	_
19	stimulates	stimulate	_	_	_	_	_	_	_
20	NF-kappaB-directed	nf-kappab-directed	_	_	_	_	_	_	_
21	transcription	transcription	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
25	gene	gene	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Consequently	consequently	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
4	protein	protein	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	chronically	chronically	_	_	_	_	_	_	_
8	downregulated	downregulate	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	HTLV-1-infected	htlv-1-infected	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	lymphocytes	lymphocyte	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	findings	finding	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
5	provide	provide	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	potential	potential	_	_	_	_	_	_	_
8	mechanism	mechanism	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	constitutive	constitutive	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	Tax-expressing	tax-expressing	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

